Simufilam (PTI-125) is an experimental medication for the treatment of Alzheimer's disease that was being developed by the American pharmaceutical firm Cassava Sciences.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.